# Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)

> **NCT04383730** · — · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 203 (actual)

## Conditions studied

- Critically Illness
- Sedation
- Invasive Mechanical Ventilation
- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Intravenous sedation
- **DRUG:** Inhaled sedation

## Key facts

- **NCT ID:** NCT04383730
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-26
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2021-09-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04383730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04383730, "Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT04383730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*